Logo-bi
Bioimpacts. 2023;13(1): 51-61. doi: 10.34172/bi.2022.23698
PMID: 36816998        PMCID: PMC9923812

Original Research

Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy

Sevda Jafari 1,2 ORCID, Saba Heydarian 1,2, Raymond Lai 3, Elnaz Mehdizadeh Aghdam 2, Ommoleila Molavi 1,2 * ORCID

Cited by CrossRef: 3


1- Amiri M, Molavi O, Sabetkam S, Jafari S, Montazersaheb S. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds. Cancer Cell Int. 2023;23(1) [Crossref]
2- Oliyapour Y, Dabiri S, Molavi O, Hejazi M, Davaran S, Jafari S, Montazersaheb S. Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells. Med Oncol. 2023;40(10) [Crossref]
3- Montazersaheb S, Farahzadi R, Fathi E, Alizadeh M, Abdolalizadeh Amir S, Khodaei Ardakan A, Jafari S. Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways. Heliyon. 2024;10(5):e26959 [Crossref]
4- Farhan M. Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. Biomedicines. 2023;11(6):1709 [Crossref]
5- Demir M, Altinoz E, Koca O, Elbe H, Onal M, Bicer Y, Karayakali M. Antioxidant and anti-inflammatory potential of crocin on the doxorubicin mediated hepatotoxicity in Wistar rats. Tissue and Cell. 2023;84:102182 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge